Generic Prescription Drug Info

The National Pharmacy Association (NPA) has welcomed the European Commission’s decision to widen access to orlistat, giving pharmacists the ability to help people who are overweight and obese with a well proven and safe medicine.
Commenting on the decision John Turk, NPA Chief Executive said:
“Our members report that many people seek advice from pharmacists on [...]

[Read more →]

The Harris Poll® finds a substantial change in the pharmaceutical drugs people buy, and how and where they buy them. In a period of just over two years, between October 2006 and December 2008, the proportion of adults who would choose generic drugs in preference to brand name prescription drugs has increased from 68% to [...]

[Read more →]

As the Obama administration and the 111th Congress set their priorities for health-care reform, the American Society of Health-System Pharmacists (ASHP) will push health policy makers to consider solutions that allow patients to benefit from the medication expertise of pharmacists. The Society has established principles that it believes should be included in any proposal for [...]

[Read more →]

Plans by the European Commission to allow drug companies to give information on prescription drugs to the public is troubling for the future objective use and funding of medicines, warn medical students in a letter to this week’s BMJ.
The students are representatives of Medsin, a student global health network, and Pharmaware, a UK campaign [...]

[Read more →]

Up to 50 per cent of medicines prescribed for long-term conditions are not taken as recommended. This can have dire consequences for patients leading to treatment failure and a worsening of their condition.
The pharmacy bodies have jointly welcomed the new guidance published by NICE, aiming to help all health professionals to engage with patients and [...]

[Read more →]

People who buy fake internet drugs could be risking their lives and supporting terrorism, according to an editorial in the February issue of IJCP, the International Journal of Clinical Practice.
Editor-in-Chief Dr Graham Jackson, a UK-based Consultant Cardiologist, has called for greater public awareness of the dangers and consequences of the counterfeit drugs market, which [...]

[Read more →]

Healthcare consumers, benefits managers, and even government officials are using the internet to buy unapproved prescription drugs illegally, according to a report to be published in the International Journal of Electronic Healthcare.
Daniel Lorence of Penn State Center for Technology Assessment, at University Park, Pennsylvania, suggests that the phenomenal growth of the internet as an [...]

[Read more →]

February is usually associated with Valentine’s Day and a plethora of hearts and a sea of red can be found abound. What people may not know is that February is also American Heart Month. Under the auspices of National Heart Failure Awareness Week observed February 8-14, the American Association of Heart Failure Nurses (AAHFN) is [...]

[Read more →]

The National Pharmacy Association (NPA) has welcomed the European Commission’s decision to widen access to orlistat, giving pharmacists the ability to help people who are overweight and obese with a well proven and safe medicine.
Commenting on the decision John Turk, NPA Chief Executive said:
“Our members report that many people seek advice from pharmacists on [...]

[Read more →]

Cardiovascular risks are at the heart of a new FDA mandate requiring additional clinical testing on type II diabetes drugs. In December 2008, the FDA released new guidelines requiring that pharmaceutical companies submit long-term cardiovascular studies for new type II antidiabetic therapies — effective immediately. This decision comes on the heels of a July 2008 [...]

[Read more →]